These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
728 related articles for article (PubMed ID: 20802523)
1. Transforming growth factor-β-induced epithelial-mesenchymal transition facilitates epidermal growth factor-dependent breast cancer progression. Wendt MK; Smith JA; Schiemann WP Oncogene; 2010 Dec; 29(49):6485-98. PubMed ID: 20802523 [TBL] [Abstract][Full Text] [Related]
2. Therapeutic targeting of the focal adhesion complex prevents oncogenic TGF-beta signaling and metastasis. Wendt MK; Schiemann WP Breast Cancer Res; 2009; 11(5):R68. PubMed ID: 19740433 [TBL] [Abstract][Full Text] [Related]
3. Src phosphorylates Tyr284 in TGF-beta type II receptor and regulates TGF-beta stimulation of p38 MAPK during breast cancer cell proliferation and invasion. Galliher AJ; Schiemann WP Cancer Res; 2007 Apr; 67(8):3752-8. PubMed ID: 17440088 [TBL] [Abstract][Full Text] [Related]
4. TGF-β stimulates Pyk2 expression as part of an epithelial-mesenchymal transition program required for metastatic outgrowth of breast cancer. Wendt MK; Schiemann BJ; Parvani JG; Lee YH; Kang Y; Schiemann WP Oncogene; 2013 Apr; 32(16):2005-15. PubMed ID: 22710711 [TBL] [Abstract][Full Text] [Related]
5. [Aberrant Activation Mechanism of TGF-β Signaling in Epithelial-mesenchymal Transition]. Yuki R Yakugaku Zasshi; 2021; 141(11):1229-1234. PubMed ID: 34719542 [TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor-β1 induces EMT by the transactivation of epidermal growth factor signaling through HA/CD44 in lung and breast cancer cells. Li L; Qi L; Liang Z; Song W; Liu Y; Wang Y; Sun B; Zhang B; Cao W Int J Mol Med; 2015 Jul; 36(1):113-22. PubMed ID: 26005723 [TBL] [Abstract][Full Text] [Related]
7. EGF induces epithelial-mesenchymal transition through phospho-Smad2/3-Snail signaling pathway in breast cancer cells. Kim J; Kong J; Chang H; Kim H; Kim A Oncotarget; 2016 Dec; 7(51):85021-85032. PubMed ID: 27829223 [TBL] [Abstract][Full Text] [Related]
8. An novel inhibitor of TGF-β type I receptor, IN-1130, blocks breast cancer lung metastasis through inhibition of epithelial-mesenchymal transition. Park CY; Min KN; Son JY; Park SY; Nam JS; Kim DK; Sheen YY Cancer Lett; 2014 Aug; 351(1):72-80. PubMed ID: 24887560 [TBL] [Abstract][Full Text] [Related]
9. Beta3 integrin and Src facilitate transforming growth factor-beta mediated induction of epithelial-mesenchymal transition in mammary epithelial cells. Galliher AJ; Schiemann WP Breast Cancer Res; 2006; 8(4):R42. PubMed ID: 16859511 [TBL] [Abstract][Full Text] [Related]
10. Grb2 binding to Tyr284 in TbetaR-II is essential for mammary tumor growth and metastasis stimulated by TGF-beta. Galliher-Beckley AJ; Schiemann WP Carcinogenesis; 2008 Feb; 29(2):244-51. PubMed ID: 18174260 [TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor-beta and epidermal growth factor synergistically stimulate epithelial to mesenchymal transition (EMT) through a MEK-dependent mechanism in primary cultured pig thyrocytes. Grände M; Franzen A; Karlsson JO; Ericson LE; Heldin NE; Nilsson M J Cell Sci; 2002 Nov; 115(Pt 22):4227-36. PubMed ID: 12376555 [TBL] [Abstract][Full Text] [Related]
12. Fibroblast growth factor receptor splice variants are stable markers of oncogenic transforming growth factor β1 signaling in metastatic breast cancers. Wendt MK; Taylor MA; Schiemann BJ; Sossey-Alaoui K; Schiemann WP Breast Cancer Res; 2014 Mar; 16(2):R24. PubMed ID: 24618085 [TBL] [Abstract][Full Text] [Related]
13. Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells. Zhang J; Thorikay M; van der Zon G; van Dinther M; Ten Dijke P J Vis Exp; 2020 Oct; (164):. PubMed ID: 33191940 [TBL] [Abstract][Full Text] [Related]
14. Lack of transforming growth factor-β signaling promotes collective cancer cell invasion through tumor-stromal crosstalk. Matise LA; Palmer TD; Ashby WJ; Nashabi A; Chytil A; Aakre M; Pickup MW; Gorska AE; Zijlstra A; Moses HL Breast Cancer Res; 2012 Jul; 14(4):R98. PubMed ID: 22748014 [TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNAs (LncRNA) regulated by transforming growth factor (TGF) β: LncRNA-hit-mediated TGFβ-induced epithelial to mesenchymal transition in mammary epithelia. Richards EJ; Zhang G; Li ZP; Permuth-Wey J; Challa S; Li Y; Kong W; Dan S; Bui MM; Coppola D; Mao WM; Sellers TA; Cheng JQ J Biol Chem; 2015 Mar; 290(11):6857-67. PubMed ID: 25605728 [TBL] [Abstract][Full Text] [Related]
16. The Src family kinase inhibitors PP2 and PP1 block TGF-beta1-mediated cellular responses by direct and differential inhibition of type I and type II TGF-beta receptors. Ungefroren H; Sebens S; Groth S; Gieseler F; Fändrich F Curr Cancer Drug Targets; 2011 May; 11(4):524-35. PubMed ID: 21395548 [TBL] [Abstract][Full Text] [Related]
17. Epithelial to mesenchymal transition promotes breast cancer progression via a fibronectin-dependent STAT3 signaling pathway. Balanis N; Wendt MK; Schiemann BJ; Wang Z; Schiemann WP; Carlin CR J Biol Chem; 2013 Jun; 288(25):17954-67. PubMed ID: 23653350 [TBL] [Abstract][Full Text] [Related]
18. Down-regulation of epithelial cadherin is required to initiate metastatic outgrowth of breast cancer. Wendt MK; Taylor MA; Schiemann BJ; Schiemann WP Mol Biol Cell; 2011 Jul; 22(14):2423-35. PubMed ID: 21613543 [TBL] [Abstract][Full Text] [Related]
19. Targeted inactivation of β1 integrin induces β3 integrin switching, which drives breast cancer metastasis by TGF-β. Parvani JG; Galliher-Beckley AJ; Schiemann BJ; Schiemann WP Mol Biol Cell; 2013 Nov; 24(21):3449-59. PubMed ID: 24006485 [TBL] [Abstract][Full Text] [Related]
20. Wild-type and mutant p53 differentially regulate NADPH oxidase 4 in TGF-β-mediated migration of human lung and breast epithelial cells. Boudreau HE; Casterline BW; Burke DJ; Leto TL Br J Cancer; 2014 May; 110(10):2569-82. PubMed ID: 24714748 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]